Mobix Labs, Inc. filed a Form 8-K on November 20, 2026, disclosing that a one-for-seven reverse stock split of its Class A Common Stock became effective at 4:00 p.m. Eastern Time on November 16, 2026.

Key Highlights

  • Reverse split ratio: Every seven shares of Class A Common Stock were converted into one share, on a one-for-seven (1:7) basis.
  • Effective date and time: The Certificate of Amendment became effective at 4:00 p.m. Eastern Time on November 16, 2026, upon filing with the Delaware Secretary of State.
  • CUSIP change: The CUSIP number for the Common Stock changed to 60743G308; the trading symbol remains "MOBX."
  • Fractional shares: No fractional shares will be issued; any fractional share resulting from the split will be rounded up to the nearest whole share.
  • Warrant exercise price adjusted: Each public warrant and private placement warrant will become exercisable for 1/7th of a share of Common Stock at an adjusted exercise price of $405.30 per share.
  • Warrants affected: Public warrants covering up to 85,715 shares and private placement warrants covering up to 48,572 shares are subject to the adjustment, according to the filing.
  • Par value and authorized shares unchanged: The reverse split did not change the par value of $0.00001 per share or the authorized number of shares of Common Stock.

Mobix Labs' 1-for-7 Reverse Stock Split: Details and Impact on Securities

According to the filing, Mobix Labs, Inc. (NASDAQ:MOBX) filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation, as amended, with the Delaware Secretary of State on November 16, 2026. The amendment implemented the reverse stock split, which the company disclosed became effective at 4:00 p.m. Eastern Time that same day. The registrant reported that the split affects all stockholders uniformly and "does not alter any stockholder's percentage ownership interest in the Company, except for adjustments related to fractional shares."

The company disclosed that the reverse stock split will also proportionately adjust the number of shares available under its equity incentive plan, as well as the exercise price and number of shares underlying stock options and warrants outstanding on the effective date, in each case in accordance with their terms. Continental Stock Transfer and Trust Company, identified in the filing as the warrant agent, has been instructed by the company to notify holders of both public and private placement warrants of the adjusted terms. Those warrants were originally issued pursuant to a Warrant Agreement between Chavant Capital Acquisition Corporation and Continental dated December 21, 2023, as stated in the filing.

The filing was signed by Keyvan Samini, President and Chief Financial Officer of Mobix Labs, Inc., and dated November 20, 2026. The Class A Common Stock and redeemable warrants (trading as MOBXW) are both listed on the Nasdaq Capital Market, as noted on the filing's cover page.

What Was Disclosed

Mobix Labs disclosed a 1-for-7 reverse stock split of its Class A Common Stock effective November 16, 2026, including the new CUSIP number, adjusted warrant exercise terms, and confirmation that par value and authorized share count remain unchanged.